Sargent Investment Group, LLC - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 25 filers reported holding ACASTI PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Sargent Investment Group, LLC ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q3 2020$3,000
-88.0%
16,750
-64.6%
0.00%
-88.9%
Q2 2020$25,000
+38.9%
47,3000.0%0.01%
+12.5%
Q1 2020$18,000
-94.2%
47,300
-62.4%
0.01%
-86.2%
Q4 2019$308,000125,7000.06%
Other shareholders
ACASTI PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Perceptive Advisors 236,559$594,0000.04%
INTACT INVESTMENT MANAGEMENT INC. 89,490$287,0000.01%
BANK OF MONTREAL /CAN/ 210,484$537,0000.00%
DEUTSCHE BANK AG\ 215$00.00%
Tower Research Capital LLC (TRC) 200$1,0000.00%
CITIGROUP INC 30$00.00%
MORGAN STANLEY 18$00.00%
Renaissance Technologies 20,900$53,0000.00%
ROYAL BANK OF CANADA 588$1,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 400$1,0000.00%
View complete list of ACASTI PHARMA INC shareholders